591 related articles for article (PubMed ID: 24114591)
21. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
22. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Li P; Jiang L; Zhang X; Liu J; Wang H
BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
[TBL] [Abstract][Full Text] [Related]
23. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.
Lee J; Suh C; Park YH; Ko YH; Bang SM; Lee JH; Lee DH; Huh J; Oh SY; Kwon HC; Kim HJ; Lee SI; Kim JH; Park J; Oh SJ; Kim K; Jung C; Park K; Kim WS
J Clin Oncol; 2006 Feb; 24(4):612-8. PubMed ID: 16380410
[TBL] [Abstract][Full Text] [Related]
24. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathologic analysis of extranodal non-hodgkin lymphoma of the sinonasal cavities: a 15-case report].
Zhang YH; Duan QC; Zuo Q; Du C; Xie LF; Zhu L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 31(21):1653-1657. PubMed ID: 29798121
[No Abstract] [Full Text] [Related]
26. Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review.
Ding W; Wang J; Zhao S; Yang Q; Sun H; Yan J; Gao L; Yao W; Zhang W; Liu W
Pathol Res Pract; 2015 Jul; 211(7):544-9. PubMed ID: 25953340
[TBL] [Abstract][Full Text] [Related]
27. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type.
Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y
Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236
[TBL] [Abstract][Full Text] [Related]
28. Dynamic Prediction of Survival for Sinonasal Extranodal Natural Killer/T-cell Lymphoma.
Wang T; Qiu Y; Shi L; Chen D; Chen X; Liu J; Liu T
Laryngoscope; 2023 Jul; 133(7):1645-1651. PubMed ID: 37294046
[TBL] [Abstract][Full Text] [Related]
29. [Radiation therapy of sinonasal natural killer/T-cell lymphoma].
Riet FG; Canova CH; Gabarre J; Ben Hassine S; Kamsu Kom L; Mazeron JJ; Feuvret L
Cancer Radiother; 2014 Mar; 18(2):147-53; quiz 161, 163. PubMed ID: 24462054
[TBL] [Abstract][Full Text] [Related]
30. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
Yhim HY; Kim JS; Mun YC; Moon JH; Chae YS; Park Y; Jo JC; Kim SJ; Yoon DH; Cheong JW; Kwak JY; Lee JJ; Kim WS; Suh C; Yang DH;
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1597-604. PubMed ID: 25963920
[TBL] [Abstract][Full Text] [Related]
31. Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China.
Liang R; Wang Z; Bai QX; Gao GX; Yang L; Zhang T; Gu HT; Dong BX; Shu MM; Hao CX; Zhang N; Chen XQ
Oncol Res Treat; 2016; 39(1-2):45-52. PubMed ID: 26891121
[TBL] [Abstract][Full Text] [Related]
32. Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort study.
Mei M; Wang Y; Zhang M
PLoS One; 2019; 14(4):e0214860. PubMed ID: 30995261
[TBL] [Abstract][Full Text] [Related]
33. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
[TBL] [Abstract][Full Text] [Related]
34. Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States.
Kommalapati A; Tella SH; Ganti AK; Armitage JO
Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):475-479. PubMed ID: 29752210
[TBL] [Abstract][Full Text] [Related]
35. A five
Vittayawacharin P; Khuhapinant A
Hematology; 2021 Dec; 26(1):75-82. PubMed ID: 33427594
[TBL] [Abstract][Full Text] [Related]
36. Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.
Kato S; Takahashi E; Asano N; Tanaka T; Megahed N; Kinoshita T; Nakamura S
Histopathology; 2012 Aug; 61(2):186-99. PubMed ID: 22690710
[TBL] [Abstract][Full Text] [Related]
37. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
[TBL] [Abstract][Full Text] [Related]
38. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
Haverkos BM; Pan Z; Gru AA; Freud AG; Rabinovitch R; Xu-Welliver M; Otto B; Barrionuevo C; Baiocchi RA; Rochford R; Porcu P
Curr Hematol Malig Rep; 2016 Dec; 11(6):514-527. PubMed ID: 27778143
[TBL] [Abstract][Full Text] [Related]
39. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type.
Cai Q; Luo X; Zhang G; Huang H; Huang H; Lin T; Jiang W; Xia Z; Young KH
Ann Hematol; 2014 Sep; 93(9):1541-9. PubMed ID: 24782120
[TBL] [Abstract][Full Text] [Related]
40. Sinonasal malignancies: A population-based analysis of site-specific incidence and survival.
Dutta R; Dubal PM; Svider PF; Liu JK; Baredes S; Eloy JA
Laryngoscope; 2015 Nov; 125(11):2491-7. PubMed ID: 26228792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]